Medscape3h
Feds Sue Three Biggest Pharmacy Benefit Managers Over Insulin Costs
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
FTC sues prescription drug middlemen, alleging they conspired over high insulin costs
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
Feds sue pharmacy gatekeepers over high insulin costs
The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
MedPage Today2d
FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
Federal Trade Commission sues Optum, two others over insulin pricing
The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...
Medscape13h
Insulin Therapy De-Escalation to Fixed-Ratio Combo Safe
MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...